The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.
about
Leflunomide: mode of action in the treatment of rheumatoid arthritisImpact of Exercise on Innate Immunity in Multiple Sclerosis Progression and SymptomatologyTeriflunomide in Patients with Relapsing-Remitting Forms of Multiple SclerosisLeflunomide inhibition of BK virus replication in renal tubular epithelial cells.New oral disease-modifying therapies for multiple sclerosis.Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.Review of teriflunomide and its potential in the treatment of multiple sclerosis.Effects of leflunomide on inflamation and fibrosis in bleomycine induced pulmonary fibrosis in wistar albino rats.Teriflunomide and its mechanism of action in multiple sclerosis.Suppressed wound healing in a patient with rheumatoid arthritis taking leflunomide (arava).Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience.
P2860
Q24675005-45884A1C-D9AF-47B2-A3F0-9D28B93CAF2AQ26745562-5F1DFBE8-1695-4DF9-A3D0-BE38DA8B0E17Q28070118-F16B630A-2322-4D84-8EF9-7B2D0AC06E58Q33614540-84C0D8DA-1B81-431D-A0E3-AB9D0A56CD7DQ34076398-AD16304F-2764-4D97-B9CC-DAE386828645Q34692643-C4E23482-30D0-4F21-AEED-C0E6BE2F2F9DQ37235715-4C756ED0-AA2D-48EE-AF0B-32DAC55E2002Q37274585-AA54C2C6-B55B-4305-B697-AC1E453CBEC2Q37730005-4143EF2F-86A9-48CD-A066-4C762300E340Q40704946-902A25B8-2D9C-4C40-896A-3EF70D4EBC0BQ41877062-F640E844-F002-4902-B9C4-3708701210B4Q47105088-CE66A42C-DFAD-4557-8BCC-C16AFA238015
P2860
The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
The immunosuppressant leflunom ...... ll cycle by a novel mechanism.
@en
The immunosuppressant leflunom ...... ll cycle by a novel mechanism.
@nl
type
label
The immunosuppressant leflunom ...... ll cycle by a novel mechanism.
@en
The immunosuppressant leflunom ...... ll cycle by a novel mechanism.
@nl
prefLabel
The immunosuppressant leflunom ...... ll cycle by a novel mechanism.
@en
The immunosuppressant leflunom ...... ll cycle by a novel mechanism.
@nl
P2093
P1476
The immunosuppressant leflunom ...... ll cycle by a novel mechanism.
@en
P2093
Cherwinski HM
McCarley D
Schatzman R
P304
P407
P577
1995-01-01T00:00:00Z